Literature DB >> 29290371

Mitochondrial Etiology of Neuropsychiatric Disorders.

Liming Pei1, Douglas C Wallace2.   

Abstract

The brain has the highest mitochondrial energy demand of any organ. Therefore, subtle changes in mitochondrial energy production will preferentially affect the brain. Considerable biochemical evidence has accumulated revealing mitochondrial defects associated with neuropsychiatric diseases. Moreover, the mitochondrial genome encompasses over a thousand nuclear DNA genes plus hundreds to thousands of copies of the maternally inherited mitochondrial DNA (mtDNA). Therefore, partial defects in either the nuclear DNA or mtDNA genes or combinations of the two can be sufficient to cause neuropsychiatric disorders. Inherited and acquired mtDNA mutations have recently been associated with autism spectrum disorder, which parallels previous evidence of mtDNA variation in other neurological diseases. Therefore, mitochondrial dysfunction may be central to the etiology of a wide spectrum of neurological diseases. The mitochondria and the nucleus communicate to coordinate energy production and utilization, providing the potential for therapeutics by manipulating nuclear regulation of mitochondrial gene expression.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Autism; Mitochondria; Nuclear receptors; OXPHOS; mtDNA

Mesh:

Substances:

Year:  2017        PMID: 29290371      PMCID: PMC5891364          DOI: 10.1016/j.biopsych.2017.11.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  118 in total

1.  Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

Authors:  Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  A mitochondrial bioenergetic etiology of disease.

Authors:  Douglas C Wallace
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

3.  Nonoxidative glucose consumption during focal physiologic neural activity.

Authors:  P T Fox; M E Raichle; M A Mintun; C Dence
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

4.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

Review 6.  Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.

Authors:  P Hemachandra Reddy; Tejaswini P Reddy; Maria Manczak; Marcus J Calkins; Ulziibat Shirendeb; Peizhong Mao
Journal:  Brain Res Rev       Date:  2010-12-08

7.  Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions.

Authors:  Di Ma; Siming Li; Elizabeth K Lucas; Rita M Cowell; Jiandie D Lin
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

8.  Leber's Hereditary Optic Neuropathy.

Authors:  Alfredo A Sadun; Chiara La Morgia; Valerio Carelli
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

9.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.

Authors:  Stephan J Sanders; Xin He; A Jeremy Willsey; A Gulhan Ercan-Sencicek; Kaitlin E Samocha; A Ercument Cicek; Michael T Murtha; Vanessa H Bal; Somer L Bishop; Shan Dong; Arthur P Goldberg; Cai Jinlu; John F Keaney; Lambertus Klei; Jeffrey D Mandell; Daniel Moreno-De-Luca; Christopher S Poultney; Elise B Robinson; Louw Smith; Tor Solli-Nowlan; Mack Y Su; Nicole A Teran; Michael F Walker; Donna M Werling; Arthur L Beaudet; Rita M Cantor; Eric Fombonne; Daniel H Geschwind; Dorothy E Grice; Catherine Lord; Jennifer K Lowe; Shrikant M Mane; Donna M Martin; Eric M Morrow; Michael E Talkowski; James S Sutcliffe; Christopher A Walsh; Timothy W Yu; David H Ledbetter; Christa Lese Martin; Edwin H Cook; Joseph D Buxbaum; Mark J Daly; Bernie Devlin; Kathryn Roeder; Matthew W State
Journal:  Neuron       Date:  2015-09-23       Impact factor: 17.173

10.  Dependence of hippocampal function on ERRγ-regulated mitochondrial metabolism.

Authors:  Liming Pei; Yangling Mu; Mathias Leblanc; William Alaynick; Grant D Barish; Matthew Pankratz; Tiffany W Tseng; Samantha Kaufman; Christopher Liddle; Ruth T Yu; Michael Downes; Samuel L Pfaff; Johan Auwerx; Fred H Gage; Ronald M Evans
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

View more
  43 in total

1.  So Happy Together: The Storied Marriage Between Mitochondria and the Mind.

Authors:  Ruth F McCann; David A Ross
Journal:  Biol Psychiatry       Date:  2018-05-01       Impact factor: 13.382

2.  Easing US restrictions on mitochondrial replacement therapy would protect research interests but grease the slippery slope.

Authors:  David L Keefe
Journal:  J Assist Reprod Genet       Date:  2019-08-28       Impact factor: 3.412

3.  Brain cytochrome-c-oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS.

Authors:  Lisa Holper; Martin J Lan; Patrick J Brown; Elizabeth M Sublette; Ainsley Burke; John J Mann
Journal:  Depress Anxiety       Date:  2019-05-21       Impact factor: 6.505

Review 4.  Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.

Authors:  M Isabel G Lopez Sanchez; Peter van Wijngaarden; Ian A Trounce
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

5.  A new opportunity: metabolism and neuropsychiatric disorders.

Authors:  Tamas Kozicz; E Morava
Journal:  J Inherit Metab Dis       Date:  2018-07       Impact factor: 4.982

6.  Mitochondrial retrograde signalling in neurological disease.

Authors:  Lucy Granat; Rachel J Hunt; Joseph M Bateman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

7.  Declining Skeletal Muscle Mitochondrial Function Associated With Increased Risk of Depression in Later Life.

Authors:  Patrick J Brown; Nicholas Brennan; Adam Ciarleglio; Chen Chen; Carolina Montes Garcia; Stephanie Gomez; Steven P Roose; Bret R Rutherford; Eleanor M Simonsick; Richard G Spencer; Luigi Ferrucci
Journal:  Am J Geriatr Psychiatry       Date:  2019-04-06       Impact factor: 4.105

Review 8.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

9.  Methylene Blue in the Treatment of Neuropsychiatric Disorders.

Authors:  Martin Alda
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 10.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.